Targeting TRIM40 signaling reduces esophagus cancer development: A mechanism involving in protection of oroxylin A
International Immunopharmacology,
Год журнала:
2024,
Номер
137, С. 112362 - 112362
Опубликована: Июнь 19, 2024
Язык: Английский
Exploring Bioactive Constituents and Pharmacological Effects of Scutellaria baicalensis Georgi: A Review
Yan Liu,
Zhixu Gao,
Yintao Zhao
и другие.
Natural Product Communications,
Год журнала:
2024,
Номер
19(8)
Опубликована: Авг. 1, 2024
Scutellaria
baicalensis,
commonly
known
as
Chinese
Skullcap,
is
a
traditional
herb
with
long
history
of
cultural
use
in
medicines.
This
review
focuses
on
comprehensive
summary
the
morphological
description,
bioactive
compounds,
drug-herb
interactions,
and
pharmacological
activities
well
its
therapeutic
applications.
A
wide-ranging
search
using
databases
such
PubMed,
Scopus,
Google
Scholar,
advanced
Web
was
conducted
for
data
collection
from
prior
studies.
The
plant
root
contains
major
active
constituents
including
flavonoids
flavo-glycosides
wogonin,
baicalein,
baicalin,
oroxylin
A,
scutellarein,
norwogonin.
These
compounds
have
demonstrated
variety
activities,
combating
inflammation,
oxidative
stress,
cancer,
neuronal
disorders,
liver
disorders.
Skullcap
represents
promising
avenue
potential
pharmacotherapeutic
formulation
advancement,
emphasizing
need
further
scientific
exploration
clinical
trials.
Язык: Английский
Efficacy of Oroxylin A in ameliorating renal fibrosis with emphasis on Sirt1 activation and TGF-β/Smad3 pathway modulation
Guangzhuang Li,
Sentao Xian,
Xian‐Chao Cheng
и другие.
Frontiers in Pharmacology,
Год журнала:
2024,
Номер
15
Опубликована: Дек. 2, 2024
Renal
fibrosis
poses
a
serious
threat
to
human
health.
At
present,
there
are
few
types
of
traditional
Chinese
medicine
used
treat
this
disease,
and
Oroxylin
A
(OA),
as
natural
product
with
multiple
biological
activities,
is
expected
be
for
the
treatment
renal
fibrosis.
Язык: Английский